Ackermans & van Haaren supports MRM Health’s Series B financing round of 55 million euros

Dear shareholder,

Dear Madam, Dear Sir,

Ackermans & van Haaren (AvH) supports the Series B financing round totaling 55 million euros of MRM Health, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology.

For AvH, this series B financing round involves an additional investment of 3 million euros and brings its total investment in MRM Health to 10.8 million euros and its fully diluted participation to 14.1%.

Please find the full press release in annex.

Best regards

Ackermans & van Haaren

Attachment

• Ackermans & van Haaren supports MRM Health’s Series B financing round (20250904)

© 2025 GlobeNewswire, Inc. All Rights Reserved.

Read More..

The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.

Breaking News: Herbal Works Inc. Appoints Greta Gaines as Chief Executive Officer

Adjusting As Life Changes